Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

G6PD Deficiency Prevalence and Targeted Elimination of Residual Plasmodium Vivax Hypnozoites in Community: Township Level Implementation in Banmauk and Moe Mauk, Myanmar

NCT06392152 is registered in ClinicalTrials.gov with Pyae Linn Aung as lead sponsor.

NCT NCT06392152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06392152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
G6PD Deficiency Prevalence and Targeted Elimination of Residual Plasmodium Vivax Hypnozoites in Community: Township Level Implementation in Banmauk and Moe Mauk, Myanmar
Lead sponsor
Pyae Linn Aung
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2019
Completion date
December 31, 2024
Enrollment
1,208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, mass drug administration, myanmar, plasmodium vivax, primaquine